A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer

被引：0
|
作者：
Heather Wakelee
George A. Fisher
机构：
[1] Stanford Clinical Cancer Center,
来源：
Investigational New Drugs | 2005年 / 23卷
关键词：
amifostine; irinotecan; phase I; colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 242
页数：1
相关论文
共 50 条
  • [1] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Wakelee, H
    Fisher, GA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 241 - 242
  • [2] Irinotecan (CPT-11) in pretreated metastatic colorectal cancer (CRC)
    Lara, MA
    Feliu, J
    Salinas, P
    Fernandez, Y
    Garcia-Giron, C
    ANNALS OF ONCOLOGY, 1998, 9 : 45 - 46
  • [3] Efficacy of CPT-11 (irinotecan) as a single agent in metastatic colorectal cancer
    Shimada, Y
    Rougier, P
    Pitot, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A : S13 - S17
  • [4] A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
    N E Schoemaker
    I E L M Kuppens
    V Moiseyenko
    B Glimelius
    M Kjaer
    H Starkhammer
    D J Richel
    R Smaaland
    K Bertelsen
    J P Poulsen
    E Voznyi
    J Norum
    D Fennelly
    K M Tveit
    A Garin
    G Gruia
    A Mourier
    D Sibaud
    P Lefebvre
    J H Beijnen
    J H M Schellens
    W W ten Bokkel Huinink
    British Journal of Cancer, 2004, 91 : 1434 - 1441
  • [5] A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
    Schoemaker, NE
    Kuppens, IELM
    Moiseyenko, V
    Glimelius, B
    Kjaer, M
    Starkhammer, H
    Richel, DJ
    Smaaland, R
    Bertelsen, K
    Poulsen, JP
    Voznyi, E
    Norum, J
    Fennelly, D
    Tveit, KM
    Garin, A
    Gruia, G
    Mourier, A
    Sibaud, D
    Lefebvre, P
    Beijnen, JH
    Schellens, JHM
    Huinink, WWT
    BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1434 - 1441
  • [6] A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer
    Yamaguchi, Yoshiyuki
    Minami, Kazuhito
    Kawabuchi, Yoshiharu
    Ohshita, Akiko
    Hironaka, Katsuji
    HEPATO-GASTROENTEROLOGY, 2008, 55 (82-83) : 407 - 411
  • [7] Phase I/II trial of gemcitabine (Gem) plus irinotecan (CPT-11) for metastatic pancreatic cancer (MPC)
    Yamai, Takuo
    Ioka, Tatsuya
    Sueyoshi, Hironari
    Takada, Ryoji
    Fukutake, Nobuyasu
    Ashida, Reiko
    Katayama, Kazuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Phase I trial of irinotecan (CPT-11) I in childhood solid tumours
    Pein, F
    Doz, F
    Frappaz, D
    Lucchi, E
    Moretti, S
    Santos, D
    Mignard, D
    Vassal, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1126 - 1126
  • [9] Phase II trial of irinotecan (CPT-11) in patients with 5-FU resistant advanced colorectal cancer
    Vicent, JM
    Aparicio, J
    Lizon, J
    Molins, C
    Alonso, JD
    Gimenez-Arnau, JM
    Camps, C
    Segura, A
    Rizo, A
    Xarles, J
    ANNALS OF ONCOLOGY, 1998, 9 : 44 - 45
  • [10] Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer
    Tsunoda, A.
    Yasuda, N.
    Nakao, K.
    Narita, K.
    Yamazaki, K.
    Watanabe, M.
    Suzuki, N.
    Kusano, M.
    ONCOLOGY, 2007, 72 (1-2) : 58 - 63
12345